Pradaxa and Xarelto Problems 2016 Highest Priority Drug Safety Problem
Filed in: Xarelto Tags: Xarelto problems
References
Oral anticoagulants the nation’s top risk of acute injury from drugs millions at risk from withdrawal symptoms FAERS: A key monitoring system suffering from continued neglect. (2017). QuarterWatch, 1-25 http://www.ismp.org/QuarterWatch/pdfs/2016Q4.pdf
M. (2015, January 06). Warfarin side effects: Watch for interactions. Retrieved from http://www.mayoclinic.org/diseases-conditions/deep-vein-thrombosis/in-depth/warfarin-side-effects/art-20047592
Robbins, R. (2016, March 10). Under siege, drug makers double down on advertising. Retrieved from https://www.statnews.com/2016/03/09/drug-industry-advertising/
Portola Pharmaceuticals receives complete response letter from FDA for biologics license application for AndexXa™ (andexanet alfa). (2016, August 17). Retrieved from http://investors.portola.com/phoenix.zhtml?c=198136&p=irol-newsArticle_pf&ID=2196085